Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Board Member, CEO at Applied Proteomics

Premium

Applied Proteomics announced this week that it has appointed Peter Klemm as CEO and James Blair to its board of directors.

Klemm is currently chairman of Pathwork Diagnostics and was previously the CEO and president of Predictive Biosciences. He was also CEO of GeneOhm Sciences, which was acquired by Becton Dickinson.

Blair is a founding partner at Domain Associates, which recently participated in API's $22.5 million Series B funding round (See story, this issue).

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.